Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

Source Data from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors

<p>Source Data</p>

Bewaard in:

Bibliografische gegevens
Hoofdauteur:	Takeru Oka (15386810) (author)
Andere auteurs:	Tsunaki Higa (15386813) (author), Osamu Sugahara (15386816) (author), Daisuke Koga (15386819) (author), Shogo Nakayama (15386822) (author), Keiichi I. Nakayama (9625916) (author)
Gepubliceerd in:	2025
Onderwerpen:	Cancer Tumor Biology Molecular and Cellular Biology Therapeutic Research and Development Cell Cycle CDKs and CDK inhibitors Drug Resistance Novel mechanisms Gastrointestinal Cancers Colorectal cancer Stem Cell Biology Cancer stem cells Tumor Heterogeneity
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items

Supplementary Table S1 from Ablation of p57<sup>+</sup> Quiescent Cancer Stem Cells Suppresses Recurrence after Chemotherapy of Intestinal Tumors
door: Takeru Oka (15386810)
Gepubliceerd in: (2025)

Table S1 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
door: Emmanuel Griessinger (16721087)
Gepubliceerd in: (2025)

Table S2 from Oxidative Phosphorylation Fueled by Fatty Acid Oxidation Sensitizes Leukemic Stem Cells to Cold
door: Emmanuel Griessinger (16721087)
Gepubliceerd in: (2025)

Table S1 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
door: Xiaoqing Cheng (16918496)
Gepubliceerd in: (2025)

Table S2 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
door: Xiaoqing Cheng (16918496)
Gepubliceerd in: (2025)

Table S3 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
door: Xiaoqing Cheng (16918496)
Gepubliceerd in: (2025)

Table S4 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
door: Xiaoqing Cheng (16918496)
Gepubliceerd in: (2025)

Table S5 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
door: Xiaoqing Cheng (16918496)
Gepubliceerd in: (2025)

Table S6 from Breast Cancer Mutations <i>HER2<sup>V777L</sup></i> and <i>PIK3CA<sup>H1047R</sup></i> Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance
door: Xiaoqing Cheng (16918496)
Gepubliceerd in: (2025)

Graphical abstract from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
door: Reza Mirzaei (15306062)
Gepubliceerd in: (2025)

Supplementary Table S1 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
door: Reza Mirzaei (15306062)
Gepubliceerd in: (2025)

Supplementary Table S2 from Single-Cell Spatial Analysis Identifies Regulators of Brain Tumor–Initiating Cells
door: Reza Mirzaei (15306062)
Gepubliceerd in: (2025)

Supplementary Table S1 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S2 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S3 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S4 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S5 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S6 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S7 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S8 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Supplementary Table S9 from <i>In Vivo</i> Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target
door: Ana Vujovic (15207479)
Gepubliceerd in: (2025)

Table S1 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
door: Lanpeng Chen (16918293)
Gepubliceerd in: (2025)

Table S2 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
door: Lanpeng Chen (16918293)
Gepubliceerd in: (2025)

Table S3 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
door: Lanpeng Chen (16918293)
Gepubliceerd in: (2025)

Table S4 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
door: Lanpeng Chen (16918293)
Gepubliceerd in: (2025)

Table S5 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
door: Lanpeng Chen (16918293)
Gepubliceerd in: (2025)

Table S6 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
door: Lanpeng Chen (16918293)
Gepubliceerd in: (2025)

Table S7 from A Single-Cell Taxonomy Predicts Inflammatory Niche Remodeling to Drive Tissue Failure and Outcome in Human AML
door: Lanpeng Chen (16918293)
Gepubliceerd in: (2025)

Table 2_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
door: Sushmitha Rajeev Kumar (22687190)
Gepubliceerd in: (2025)

Table 1_How artificial intelligence can enable personalized mesenchymal stem cell–based therapeutic strategies in systemic lupus erythematosus.docx
door: Sushmitha Rajeev Kumar (22687190)
Gepubliceerd in: (2025)

Video 2_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
door: Minxia Ke (4889887)
Gepubliceerd in: (2025)

Data Sheet 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.docx
door: Minxia Ke (4889887)
Gepubliceerd in: (2025)

Video 1_Doxorubicin induces cardiotoxicity by enhancing autophagy via mTOR signaling in hiPSC- and hESC-derived cardiomyocytes.mp4
door: Minxia Ke (4889887)
Gepubliceerd in: (2025)

Data Sheet 1_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.csv
door: Zhongyi Zhang (219440)
Gepubliceerd in: (2025)

Data Sheet 2_MRI-based radiomic clustering identifies a glioblastoma subtype enriched for neural stemness and proliferative programs.pdf
door: Zhongyi Zhang (219440)
Gepubliceerd in: (2025)

Figure 1 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Figure 2 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Figure 3 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Figure 4 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Figure 5 from Exploiting Natural Killer Cell Engagers to Control Pediatric B-cell Precursor Acute Lymphoblastic Leukemia
door: Natalia Colomar-Carando (14611340)
Gepubliceerd in: (2025)

Cannot write session to /tmp/vufind_sessions/sess_qnacc5i546covbmhqj285k5d0r